BETNOVATE-C is a potent, dual-action prescription dermatological cream manufactured by GlaxoSmithKline (GSK), a global leader in pharmaceutical research and healthcare. This combination cream is a cornerstone treatment for a specific category of inflammatory skin disorders—those that have become secondarily infected with fungi or bacteria. Containing two active ingredients, Betamethasone (as Betamethasone Valerate 0.1% w/w) and Clioquinol (3% w/w), BETNOVATE-C works to simultaneously suppress inflammation, alleviate distressing symptoms, and combat microbial infection.
It is crucial to understand that BETNOVATE-C is a prescription-only medication (Schedule H in many regions). This description is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. A qualified healthcare professional must evaluate your condition to determine if BETNOVATE-C is appropriate for you.
The efficacy of BETNOVATE-C stems from the synergistic combination of its two active components, each targeting a distinct aspect of complex skin conditions:
Betamethasone Valerate (0.1% w/w): This is a corticosteroid (steroid) of potent strength. Corticosteroids are synthetic versions of hormones naturally produced by the adrenal glands. When applied topically:
Powerful Anti-inflammatory Action: It rapidly reduces inflammation (redness, swelling, and heat) in the affected skin area by inhibiting the release of inflammatory chemicals from immune cells.
Effective Anti-pruritic Relief: It suppresses the intense itching (pruritus) that is a hallmark of conditions like eczema and dermatitis, providing significant comfort and breaking the "itch-scratch cycle" that often worsens the skin.
Vasoconstrictive Effect: It causes constriction of the small blood vessels in the skin, which directly reduces redness and edema.
Clioquinol (3% w/w): This is an antimicrobial agent with both antifungal and antibacterial properties. It is particularly effective against a broad spectrum of organisms commonly responsible for secondary skin infections, including:
Fungi: Such as Candida albicans (causing candidiasis) and dermatophytes.
Bacteria: Including many Gram-positive and some Gram-negative bacteria.
Clioquinol works by chelating (binding) essential metal ions (like iron and copper) that these microorganisms require for growth and metabolism, thereby killing them or inhibiting their proliferation.
BETNOVATE-C is specifically indicated for the short-term treatment of acute, inflamed, and infected steroid-responsive dermatoses. This includes conditions where the skin's barrier is compromised due to inflammation, making it vulnerable to microbial overgrowth. Typical conditions a dermatologist may prescribe BETNOVATE-C for include:
Infected Eczema (Atopic Dermatitis): When the classic dry, itchy, inflamed patches of eczema become weepy, crusted, or show signs of bacterial (often Staphylococcus) or fungal infection.
Psoriasis (particularly in flexures or when secondarily infected): For plaques that have become inflamed and infected.
Contact Dermatitis: Allergic or irritant reactions that have been complicated by infection due to scratching or exposure to pathogens.
Seborrhoeic Dermatitis (when severe or infected): Especially in body folds.
Lichen Simplex Chronicus: Thickened, leathery skin due to chronic scratching, which can easily become infected.
Important Note: BETNOVATE-C is NOT intended for use on viral infections (e.g., herpes simplex/cold sores, chickenpox, shingles), acne, rosacea, perioral dermatitis, or on untreated bacterial or fungal infections without significant inflammation. Misuse can worsen these conditions.
Adherence to your doctor's instructions is paramount for safety and effectiveness.
Preparation: Wash and gently dry the affected skin area thoroughly before application.
Application: Apply a thin smear of the cream. Gently massage it into the skin until it disappears. A common guideline is the "fingertip unit" (FTU)—the amount squeezed from the tube to cover an adult fingertip. One FTU is sufficient to cover an area twice the size of an adult hand.
Frequency: Typically, a doctor will advise applying the cream once or twice daily. The "minimal effective dose" principle applies—use the smallest amount needed to control symptoms.
Duration: This is a short-term treatment. Your doctor will specify the treatment duration, usually not exceeding one to two weeks without review. Long-term continuous use should be avoided unless under strict medical supervision.
Occlusive Dressings: Do not use tight bandages or dressings unless explicitly directed by your doctor, as they can significantly increase the absorption of the steroid, raising the risk of systemic side effects and skin atrophy.
Prescription Only: Never use this medication without a prescription or on conditions for which it was not prescribed.
Hypersensitivity: Do not use if you have a known allergy to betamethasone, clioquinol, other corticosteroids, iodine, or any cream ingredient.
Pregnancy & Lactation: Use during pregnancy or breastfeeding is generally not recommended unless the potential benefit outweighs the risk. Consult your doctor.
Children & Infants: Use in children requires extra caution and medical supervision due to their higher skin surface area to body weight ratio, which increases systemic absorption risk.
Avoid the Face & Sensitive Areas: Unless prescribed, avoid use on the face, groin, armpits, or other thin-skinned areas due to higher risk of side effects like thinning skin, striae (stretch marks), and telangiectasia (visible blood vessels).
Potential Side Effects:
Local Skin Reactions (common with prolonged use): Skin thinning (atrophy), stretch marks, increased hair growth, perioral dermatitis, acneiform eruptions, allergic contact dermatitis, and changes in skin color.
Systemic Absorption (with extensive/long-term use): Can lead to effects similar to oral steroid use, such as adrenal suppression, Cushing's syndrome, hyperglycemia, and growth retardation in children.
Clioquinol-related: Can stain skin, hair, or fabrics yellow/brown. Rarely, may cause skin irritation.
When prescribed BETNOVATE-C, you are receiving a product from GlaxoSmithKline (GSK), a company with a long-standing legacy in dermatology. This ensures:
Assured Quality & Consistency: Manufactured under stringent Good Manufacturing Practice (GMP) standards.
Clinically Proven Formulation: The efficacy and safety profile of the betamethasone and clioquinol combination are well-established through extensive clinical use and research.
Trusted Heritage: GSK is a name trusted by healthcare professionals worldwide for reliable and effective medicinal products.
BETNOVATE-C Cream is a powerful and effective solution for managing inflamed and infected steroid-responsive skin conditions. Its dual-action formula addresses both the underlying inflammatory process and the complicating microbial infection, providing comprehensive relief. However, its potency demands respect and responsible use strictly under medical guidance. Do not self-medicate. If you are experiencing a skin condition you believe may require this treatment, consult a dermatologist or your physician for a proper diagnosis and personalized treatment plan.
Disclaimer: This information is intended for educational purposes. Always read the package insert provided with the medication and follow your healthcare provider's advice. Dosage, indications, and warnings may vary by region. Report any unexpected side effects to your doctor immediately.
On all orders is set at $25.00
Protected by Bitcoin
On all huge orders
Madelyn Hill
This product is a game-changer. It has made my life so much easier. Highly recommended!
James Bell
I recently made a purchase from this website and I am extremely satisfied. The product arrived on time and the customer service was excellent. Will definitely be a repeat customer!